| 000 | 01820 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515040838.0 | ||
| 264 | 0 | _c20070103 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0960-894X | ||
| 024 | 7 |
_a10.1016/j.bmcl.2006.08.085 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aElliott, Jason M | |
| 245 | 0 | 0 |
_aN',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cNov 2006 |
||
| 300 |
_a5752-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aFluorine _xchemistry |
| 650 | 0 | 4 |
_aHydrazines _xchemistry |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xpharmacology |
| 650 | 0 | 4 |
_aPiperazines _xchemistry |
| 650 | 0 | 4 |
_aQuinolines _xchemistry |
| 650 | 0 | 4 |
_aReceptors, Neurokinin-3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aCarling, Robert W | |
| 700 | 1 | _aChicchi, Gary G | |
| 700 | 1 | _aCrawforth, James | |
| 700 | 1 | _aHutson, Peter H | |
| 700 | 1 | _aJones, A Brian | |
| 700 | 1 | _aKelly, Sarah | |
| 700 | 1 | _aMarwood, Rose | |
| 700 | 1 | _aMeneses-Lorente, Georgina | |
| 700 | 1 | _aMezzogori, Elena | |
| 700 | 1 | _aMurray, Fraser | |
| 700 | 1 | _aRigby, Michael | |
| 700 | 1 | _aRoyo, Inmaculada | |
| 700 | 1 | _aRussell, Michael G N | |
| 700 | 1 | _aShaw, Duncan | |
| 700 | 1 | _aSohal, Bindi | |
| 700 | 1 | _aTsao, Kwei Lan | |
| 700 | 1 | _aWilliams, Brian | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 16 _gno. 22 _gp. 5752-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2006.08.085 _zAvailable from publisher's website |
| 999 |
_c16534627 _d16534627 |
||